Literature DB >> 17498659

Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.

Hongbin Sun1, Jiangxin Liu, Jiahai Zhang, Weiqun Shen, Hongda Huang, Chao Xu, Haiming Dai, Jihui Wu, Yunyu Shi.   

Abstract

BRD7 is an important protein tightly associated with Nasopharyngeal carcinoma (NPC). Overexpression of BRD7 inhibits NPC cell growth and cell cycle by transcriptionally regulating the cell cycle related genes. BRD7 contains a bromodomain that is found in many chromatin-associated proteins and in nearly all known nuclear histone acetyltransferases (HATs) and plays an important role in chromatin remodeling and transcriptional activation. Here, we report the solution structure of BRD7 bromodomain determined by NMR spectroscopy, and its binding specificity revealed by NMR titration with several acetylated histone peptides. We find that BRD7 bromodomain contains the typical left-handed four-helix bundle topology, and can bind with weak affinity to lysine-acetylated peptides derived from histone H3 with K9 or K14 acetylated and from histone H4 with K8, K12 or K16 acetylated. Our results show that BRD7 bromodomain lacks inherent binding specificity when binding to histones in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498659     DOI: 10.1016/j.bbrc.2007.04.139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Keeping it in the family: diverse histone recognition by conserved structural folds.

Authors:  Kyoko L Yap; Ming-Ming Zhou
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-06       Impact factor: 8.250

Review 2.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

3.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.

Authors:  Ke Xu; Wei Xiong; Ming Zhou; Heran Wang; Jing Yang; Xiayu Li; Pan Chen; Qianjin Liao; Hao Deng; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng
Journal:  Mol Cell Biochem       Date:  2015-09-25       Impact factor: 3.396

4.  NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex.

Authors:  Noelle M Olson; Samantha Kroc; Jorden A Johnson; Huda Zahid; Peter D Ycas; Alice Chan; Jennifer R Kimbrough; Prakriti Kalra; Ernst Schönbrunn; William C K Pomerantz
Journal:  Biochemistry       Date:  2020-05-11       Impact factor: 3.162

Review 5.  Biological function and histone recognition of family IV bromodomain-containing proteins.

Authors:  Jonathan T Lloyd; Karen C Glass
Journal:  J Cell Physiol       Date:  2017-06-13       Impact factor: 6.384

6.  Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.

Authors:  Amanda Poplawski; Kaifeng Hu; Woonghee Lee; Senthil Natesan; Danni Peng; Samuel Carlson; Xiaobing Shi; Stefan Balaz; John L Markley; Karen C Glass
Journal:  J Mol Biol       Date:  2013-12-12       Impact factor: 5.469

7.  BRD7 is a candidate tumour suppressor gene required for p53 function.

Authors:  Jarno Drost; Fiamma Mantovani; Francesca Tocco; Ran Elkon; Anna Comel; Henne Holstege; Ron Kerkhoven; Jos Jonkers; P Mathijs Voorhoeve; Reuven Agami; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2010-03-14       Impact factor: 28.824

8.  Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.

Authors:  Rezaul Md Karim; Alice Chan; Jin-Yi Zhu; Ernst Schönbrunn
Journal:  J Med Chem       Date:  2020-03-06       Impact factor: 7.446

Review 9.  Polybromo-1: the chromatin targeting subunit of the PBAF complex.

Authors:  Martin Thompson
Journal:  Biochimie       Date:  2008-12-03       Impact factor: 4.079

10.  Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Authors:  Minghua Wu; Xiayu Li; Xiaoling Li; Guiyuan Li
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.